Related Experiment Videos

[Lipid profile of patients with increased risk for cardiovascular events in daily clinical practice]

Rodrigo O Moreira1, Raul D Santos, Lilton Martinez

  • 1Instituto Estadual de Diabetes e Endocrinologia, Rio de Janeiro, RJ. rom_br@yahoo.com

Arquivos Brasileiros De Endocrinologia E Metabologia
|August 29, 2006
PubMed

Insights

Despite guidelines for dyslipidemia treatment in high-risk patients, adherence is poor. This study found few patients achieve target cholesterol levels, even with lipid-lowering drugs (LLD), indicating a need for intensified therapy.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Context:

  • Dyslipidemia management in high-risk patients is crucial for cardiovascular disease prevention.
  • Current treatment guidelines for dyslipidemia exist but are often not followed.
  • High-risk patients in Brazil and Venezuela were assessed for cardiovascular risk factors and treatment adherence.

Purpose:

  • To investigate risk factors and treatment patterns in high-risk cardiovascular patients in Brazil and Venezuela.
  • To evaluate the effectiveness of lipid-lowering drugs (LLD), particularly statins, in managing dyslipidemia.
  • To determine the percentage of patients achieving guideline-recommended cholesterol levels.

Summary:

  • A study of 412 patients revealed that those not using LLD had significantly higher total cholesterol, LDL, and HDL, and lower triglycerides.
  • Statin use was associated with reductions in total cholesterol, LDL, HDL, and triglycerides.
  • Only a small proportion of patients, even those on LLD, met current dyslipidemia treatment guidelines.

Impact:

  • Findings highlight suboptimal adherence to dyslipidemia treatment guidelines in high-risk populations.
  • Suggests a need for intensified therapeutic strategies, such as increased statin dosage or combination therapy.
  • Emphasizes the gap between established guidelines and clinical practice in managing cardiovascular risk.

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...